Position paper: Models of post-transplant care for individuals with cystic fibrosis
Open Access
- 5 March 2023
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (3) , 374-380
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Foundation
This publication has 8 references indexed in Scilit:
- Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantationPediatric Pulmonology, 2022
- Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipientsJournal of Cystic Fibrosis, 2022
- CFTR modulator use in post lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2021
- Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2021
- To treat or not to treat: CFTR modulators after lung transplantationPediatric Transplantation, 2021
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size matchThe Journal of Heart and Lung Transplantation, 2019
- Waiting list outcomes in pediatric lung transplantation: Poor results for children listed in adult transplant programsThe Journal of Heart and Lung Transplantation, 2017